Binucleated cells could be the key in heart regeneration Blog Post

A team of researchers, led by Xavier Trepat, from the Institute of Bioengineering of Catalonia (IBEC) in collaboration with the Centre for Regenerative Medicine in Barcelona (CMR [B]), have discovered a surprising mechanism that generates binucleated cells during the regeneration of the heart of the zebrafish, and could be associated with the extraordinary regenerative power of this animal. The results of the work has attracted the attention of researchers from all over the world, who see the range of possibilities that would be opened up if this mechanism of cell regeneration could be applied in human therapies.

 

The European project GLAM develops a multiplexed biosensor for personalized diagnosis and therapy for bladder cancers Blog Post

A European consortium led by Centre Tecnològic Leitat –through its Biomed Division in the Barcelona Science Park (PCB)– has finished the GLAM project, the aim of which was to develop a photonic biosensor for a non-invasive diagnosis and personalized therapy for bladder cancers. The project involved the participation of 10 European organizations with resources and capabilities from the academia and scientific and business field, among them the Institute for Bioengineering of Catalonia (IBEC), which is also located in PCB.

 

Record-breaking turnout at Bio€quity from the Barcelona Science Park Blog Post

On 20 and 21 May, Barcelona played host for the first time to Bio€quity Europe, the main investment event focussing on the European biopharmaceutical industry, thanks to an initiative from the Comité Anfitrión Regional (Regional Hosting Committee) comprising Biocat, CataloniaBio & HealthTech, ACCIÓ and Ysios Capital. A dozen companies from the Barcelona Science Park (PCB) were chosen by the organisation as some of the 80 most promising biotechnologies in Europe to present their project to the 550 investors, business developers and experts into biopharmaceutical licensing that attended the event.

 

GlyCardial Diagnostics wins the EmprendedorXXI 2019 Award in the ‘Health Tech’ category Blog Post

GlyCardial Diagnostics has won the  the EmprendedorXXI Award in the ‘Health Tech’ category, one of the six awards granted in its twelfth year to recognize those companies in Spain and Portugal with greatest growth potential in several sectors linked to the new innovation trends. The winners have been selected from 961 companies in Spain and Portugal. The biotechnology company, headquartered in the Barcelona Science Park, adds this award to the EmprendedorXXI Award in Catalonia, which it received on 9 May.

 

Ona Therapeutics hits the road thanks to Sabadell Asabys Blog Post

Today Ona Therapeutics, the new IRB Barcelona spin-off, announced the close of a seed funding round of € 1.5M given by Sabadell Asabys, a fund managed by Asabys Partners and devoted to investments in health innovation. With this injection of capital, the company, based in the Barcelona Science Park, will begin work on the development of a new drug for the treatment of metastatic cancer.

 

OilFlux opens a R&D&i center at the Barcelona Science Park Blog Post

OilFlux, specialized in the development of technology that increases the efficiency of processes within the crude oil industry, has opened a R&D&i centre at the Barcelona Science Park. The objective of the company –which develops, manufactures and distributes its products to countries across all five continents– is to increase the quality of the ongoing research and development (R&D) of its formulations to resolve the problems associated with the crude oil and natural gas extraction processes and to reduce the environmental impact as well.

 

Characterisation of the structure and function of a member of the L-Amino acid Transporter (LAT) family Blog Post

Scientists at the Institute for Research in Biomedicine (IRB Barcelona) in the Barcelona Science Park and the CIBER of Rare Diseases (CIBERER) – in collaboration with the Institute of Molecular Biology of Barcelona (IBMB-CSIC) at PCB, and the Barcelona Supercomputing Center-Centro Nacional de Supercomputación (BSC-CNS) – have now characterised the structure of a member of the LAT family. Mutations in L-amino acid transporters (LATs) can lead to a wide range of conditions, such as autism, hearing loss and aminoacidurias. The work has been published in the journal Nature Communications.

 

World’s first baby is born in Greece through of Maternal Spindle Transfer technique developed by Embryotools Blog Post

Through pioneering clinical research, Embryotools, based in the Barcelona Science Park, and Institute of Life in Athens have achieveg birth of the world’s first healthy baby through the pioneering Maternal Spindle Transfer method to solve infertility problems. This technique was implemented by the Greek IVF center and Spanish research center to address fertility issues associated with multiple in vitro fertilization (IVF) failures caused by cytoplasmic dysfunction of the oocytes or rare mitochondrial genetic diseases.